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Squamous cell carcinoma (oral SCC) is the most common oral cancer in the U.S., aﬀecting nearly 30,000 Americans each year.
Despite recent advances in detection and treatment, there has been little improvement in the ﬁve-year survival rate for this
devastating disease. Oral cancer may be preceded by premalignant disease that appears histologically as dysplasia. Identiﬁcation
of molecular markers for cellular change would assist in determining the risk of dysplasia progressing to oral squamous cell
carcinoma. The goal of this study was to determine if any correlation exists between histological diagnosed dysplasia and OSCC
lesions and altered expression of desmosomal cell-cell adhesion molecules in the oral epithelium. Our data showed that oral SCC
tissue samples showed decreased immunoreactivity of both desmoplakin and plakophilin-1 proteins compared to normal oral
epithelium. Furthermore, signiﬁcant decrease in desmoplakin immunoreactivity was observed in dysplastic tissue compared to
normal oral epithelium. In contrast, the level of desmoglein-1 staining was unchanged between samples however desmoglein-
1 was found localized to cell borders in oral SCC samples. These data suggest that changes in expression of desmoplakin and
plakophilin-1 may prove to be a useful marker for changes in tissue morphology and provide a tool for identifying pre-neoplastic
lesions of the oral cavity.
1.Introduction
Oral cancer aﬀects 3% of the United States population and it
is estimated that 35,000 new cases will be diagnosed this year
[1]. Despite recent advancements in detection and treatment
of oral SCC, survival has only modestly improved in the past
30 years (reviewed in [2]). Changes in tumor cell migration
and interactions with the extracellular environment have
been demonstrated to promote the progression of many
solidtumors.Alterationsinadhesivecharacteristicsofcancer
cells allow rapidly growing tumor cells to detach from their
neighbors, inﬁltrate the underlying stroma, and disseminate
to distant sites in the body establishing a tumor metastasis.
Therefore understanding the changes in adhesion molecule
expressionisimportantfordeterminingtheinvasivecapacity
of cells in a tissue and predicting the likelihood of metastasis.
Ithasbeenproposedthatareasoforaldysplasiamayprogress
to oral SCC over time [3, 4] and therefore can be considered
premalignant lesions. However, diagnosing dysplasia using
tissue morphology is subjective and depends upon the
training and experience of the oral pathologist. Therefore,
identiﬁcationofmolecularmarkersforcellularchangewould
assist in recognition of premalignant lesions and assist in
determining the risk of dysplasia progressing to malignancy.
Characterization of novel markers would also assist in earlier
diagnosis and thereby improve the prognosis of oral cancer.
Desmosomes are the most prominent cell-cell junctional
complex in stratiﬁed squamous epithelial tissues. Loss of
desmosomes in various types of carcinomas is associated
with increased migratory capacity of the tumor cells [5–7].
The transmembrane core of the desmosome is comprised
of single pass desmosomal cadherins (desmogleins and
desmocollins) that are believed to interact heterotypically







Figure 1: Morphologic evaluation of normal oral mucosa (a), dysplastic oral mucosa (b), and oral squamous cell carcinoma (c). Represent-
ative sections were stained with Hematoxylin and eosin to verify the initial diagnosis of the tissue blocks used in the present study.
cell-cell adhesion [8, 9]. In addition to the desmosomal
cadherins,therecentlyidentiﬁedtetraspanprotein,PERPhas
also been shown to localize to the desmosome and aﬀect
desmosome assembly in keratinocytes [10]. The cytoplasmic
domainofthedesmosomalcadherinsassociatesdirectlywith
several desmosomal plaque proteins, including plakoglobin
and plakophilins that in turn recruit the keratin intermediate
ﬁlament cytoskeleton via interactions with desmoplakin
[11]. Assembly of the desmosomal junction allows the
keratin intermediate ﬁlament cytoskeleton to stretch across
cells and provide epithelial tissues a mechanism to withstand
mechanical stress. Inactivation of speciﬁc desmosomal adhe-
sion complexes by autoimmune sera as seen in pemphigus
vulgaris or pemphigus foliaceus results in epidermal blisters
[12].
Inherited mutations in desmosomal genes have been
identiﬁed that result in various skin, hair, and heart
defects (reviewed in [13, 14]). Mutations in plakophilin-1
are associated with ectodermal dysplasia and skin fragility
syndrome [15] while mutations in desmoglein-1 are asso-
ciated with striate palmoplantar keratoderma. Mutations
in desmoplakin and plakophilin-2, two genes encoding
desmosomal components expressed in the heart, have been
implicated in the development of arrhythmogenic right
ventricular cardiomyopathy (ARVC) [16]. ARVC patients
exhibit ﬁbro-fatty replacement of the heart muscle which
can result in sudden cardiac death. Often patients harboring
desmoplakin mutations can also exhibit defects in hair and
skin due to disruption of desmosomes in these epithelial
tissues.
Given these ﬁndings, we hypothesize that altered expres-
sion and/or localization of the desmosomal proteins may
result as cells become dysplastic and eventually progress
to squamous cell carcinoma. While many studies have
described the localization and expression of desmosomal
components in skin and skin tumors, relatively little is
known regarding desmosomal component expression in
tumors arising from the oral mucosa. In this study we
examined the expression of two desmosomal plaque pro-
teins, desmoplakin and plakophilin-1. Desmoplakin is found
in desmosomes in all the living layers of the epidermis
whileplakophilin-1 ismosthighlyexpressedindiﬀerentiated
layers. Additionally, we examined the expression of the
diﬀerentiation speciﬁc desmosomal cadherin, desmoglein-
1. In this study we hypothesized that changes in differ-
entiation speciﬁc components are more likely to exhibit
changes in expression between normal and dysplastic sam-
ples. These changes are likely to be maintained in oral SCC
samples.
2.MaterialsandMethods
2.1. Tissue Procurement and Immunostaining. Archival tissue
sections from The UNMC Oral Pathology service were
obtained with approval from the UNMC Institutional
Review Board. Eight of normal (oral buccal mucosa) ﬁfteen
histologically conﬁrmed dysplasia samples and ﬁfteen oral
squamous cell carcinoma samples were used for analysis.
All paraﬃn embedded tissue sections cut into 5μms e c -
tions and collected onto charged Superfrost slides (Elec-
tron Microscopy Sciences, Hatﬁeld, PA.). Formalin ﬁxed
paraﬃn embedded sections were dewaxed using xylene
and rehydrated through a graded alcohol series and water.
Antigen retrieval was achieved by microwave treatment for 5
minutes in freshly prepared 10mM Sodium citrate (pH 6.0).
Tissues were incubated in blocking buﬀer (1x phosphate
buﬀered saline, 0.1% Triton x-100, and 1% bovine serum
albumin) for 30 minutes prior to incubation with primary
antibodies overnight at 4◦C. Excess primary antibodies were
removed by extensive washing with 1x phosphate-buﬀered
saline. Tissues were incubated with appropriate FITC-
conjugated antimouse secondary antibodies and mounted
in vectashield mounting media containing DAPI (Vector
Laboratories, Burlingame, CA). Images were collected on
a Zeiss axiovert 200M microscope and axiocam CCD
camera using SlideBook software from Intelligent Imaging
Innovations (Denver, CO.)
2.2.Antibodies. Mousemonoclonalantidesmoplakin(10F6),
plakophilin-1, and desmoglein-1 were generated in our
laboratoryaspreviouslydescribed[17,18].Antidesmoplakin
antibody 10F6 recognizes the carboxy terminal domain
of human desmoplakin (AA 1960-2151). Generation of
antiplakophilin-1 and antidesmoglein-1 monoclonal anti-









Figure 2: Representative antidesmoplakin staining of oral tissues. Antidesmoplakin monoclonal antibody (10F6) was used to stain normal
oral mucosa (a), dysplastic oral mucosa (b), and oral squamous cell carcinoma (c). Normal oral mucosa processed in the absence of primary
antibody serves as a negative control (d). The scale bar in panel A corresponds to 20μm.
2.3. Evaluation of Staining Behavior. Immunostaining was
evaluated in a semiquantitative system based on the scoring
of at least three independent evaluators. Scoring was based
on overall staining throughout the tissue rather that staining
at one ﬁeld of view. As a negative control, normal oral
mucosa was processed without the primary antibodies and
this signal intensity was determined to be background. A
numerical score for each sample was assigned based on
the following scale. Intense cell border signal and relatively
weak cytoplasmic signal was given a score of “3”, moderate
cell border and cytoplasmic staining intensity was given a
score of “2”, overall weak staining intensity was scored a
“1”, and staining intensity similar to background levels was
scored “0”. For plakophilin-1 immunostaining, the observers
were instructed to judge the nuclear signal together with the
cytoplasmicsignaltoarriveatanoverallsignalintensityscore
since the nuclear signal was often heterogeneous throughout
a given tissue sample. Statistical analysis of scores was
carried out by ANOVA analysis and signiﬁcant diﬀerences
were determined by Kruskal-wallis multiple comparisons.
3. Results andDiscussion
To begin our analysis we selected a panel of previously
diagnosed dysplasia and oral SCC tissue samples available
as part of the UNMC oral pathology biopsy service within
the college of dentistry. We selected ﬁfteen dysplasia samples
and ﬁfteenoral SCC samples to be compared to eight normal
oral mucosa samples. Dysplastic tissues were chosen based
on the presence of basal cell layer hyperplasia, cellular pleo-
morphism, increased mitotic ﬁgures, and disorganization
of stratiﬁcation within the epithelium compared to normal
oral mucosa (Figure 1(b)). For the purposes of this study
we chose not to further stratify the dysplasia samples due
to the high degree of subjectivity in the diagnosis of these
samples. Oral SCC samples corresponded to moderately
diﬀerentiatedsquamouscellcarcinomasasdiagnosedbyoral
pathologists within the UNMC biopsy service (Figure 1(c)).
Normal oral mucosa was obtained from samples exhibiting
underlying ﬁbroma with normal appearing surface epithe-
lium (Figure 1(a)). Hematoxylin and eosin staining of the
tissue was used to reconﬁrm the diagnosis and representative
sections are shown in Figure 1.
Previous reports have demonstrated that desmosomal
component expression is often reduced or absent in oral
SCC when compared to normal epithelium [5, 20]. For our
analysis we chose to include dysplastic samples to determine
if loss of desmosomal adhesion is an early event in the
progression to squamous cell carcinoma. We stained a panel
of tissues using monoclonal antibodies speciﬁc for human
desmosomal components (desmoplakin, plakophilin-1, and
desmoglein-1) and compared the staining patterns of dys-
plastic and oral SCC samples to that of normal oral mucosa.
Desmoplakin is an obligatory component of the desmo-
somal plaque that has been shown to play an essential role in
recruiting the keratin intermediate ﬁlament cytoskeleton to
sites of cell-cell adhesion. As expected, desmoplakin staining
in normal oral mucosa displayed an intense staining pattern










oral mucosa (a), dysplastic oral mucosa (b), and oral squamous cell carcinoma (c). Normal oral mucosa processed in the absence of primary
antibody serves as a negative control (d). The scale bar in panel A corresponds to 20μm.
epidermis (Figure 2(a)). Some diﬀuse cytoplasmic signal was
observed;howeverthissignalwasminorcomparedtothecell
border staining. Some faint nuclear signal was also present
that was determined to be background signal arising from
the secondary antibody since this signal was also seen in the
negative control samples in which the antibody was omitted
(Figure 2(d)).
Desmoplakin immunostaining of oral dysplastic tissues
revealed a disruption in the desmosomal localization of
desmoplakin resulting in diﬀuse cytoplasmic localization.
In addition, there was a decrease in the overall intensity of
the antidesmoplakin signal (Figure 2(b)). Areas of relatively
normal desmoplakin localization could be seen but these
regions were small and did not extend throughout the
dysplastic tissues (data not shown). Staining of oral SCC
samples with antidesmoplakin antibodies revealed relatively
low protein expression in several samples; however the small
amount of desmoplakin that was present could be seen
localized at cell borders in a pattern similar to that seen
in normal tissues (Figure 2(c)). Most oral SCC samples
displayed no antidesmoplakin immunoreactivity and were
scored as negative.
Semiquantitative scoring was performed to assess the
desmoplakin signal intensity across the panel of tissues. At
least three independent observers were trained to recog-
nize normal cell border-associated desmoplakin staining in
normal tissues and negative background signal associated
with a negative control tissue. Identiﬁers were removed
from the slides and scores were recorded. Desmoplakin
staining in normal oral mucosa samples scored highest while
staining in dysplastic samples and oral SCC samples scored
signiﬁcantly lower (Figure 5). These data suggest that loss of
antidesmoplakin immunoreactiviy is detectable during the
transition from normal to dysplasia in the oral cavity.
Plakophilins are a family of armadillo repeat proteins
that play an important role in assembly and maintenance of
the desmosome [14, 21]. Interestingly, plakophilin-1 has also
been identiﬁed as a nuclear protein in cultured cells derived
from stratiﬁed epithelial tissues [22, 23]. Plakophilin-1
has been reported to be highly expressed in the most
diﬀerentiated layers of stratiﬁed squamous epithelium such
as skin [7, 24]. Unlike plakophilin-1 localization in the
keratinizing epithelium of the skin, plakophilin-1 localized
to all the living layers of the epithelium in the oral mucosa
(Figure 3(a)). This diﬀerence in expression is likely to reﬂect
ad i ﬀerence between keratinized and nonkeratinized tissues.
In addition to the expected cell border localization of









Figure 4: Representative anti-desmoglein-1 staining of oral tissues. Anti-desmoglein-1 monoclonal antibody (27B2) was used to stain
normal oral mucosa (a), dysplastic oral mucosa (b), and oral squamous cell carcinoma (c). Normal oral mucosa processed in the absence of





























Figure 5: Semiquantitative scoring of desmosomal component
expression. Relative intensity of desmoplakin, plakophilin-1, and
desmoglein-1 was scored by three observers and the average score
is presented (+ or − the standard error) for normal oral mucosa
(N), dysplastic epithelium (D), and oral squamous cell carcinoma
(S) (∗ : z value > 2.394 indicate signiﬁcant diﬀerence).
intense nuclear localization of plakophilin-1. The cell border
signal seen for plakophilin-1 resembled that of desmoplakin
although the intensity was somewhat reduced. The majority
of plakophilin-1 signal seen in normal samples was con-
centrated in the nucleus (Figure 3(a))a n do f t e no b s c u r e d
the signal seen at the cell periphery. Nuclear localization of
plakophilin-1 in cultured cells has been previously reported
[22,25,26].Nuclearlocalizationofplakophilin-1informalin
ﬁxed tissues is not homogenous throughout the individual
tissues. Some areas of the tissue were observed in which
no nuclear plakophilin-1 was observed while strong cell
border staining was present. Currently, the nuclear func-
tion of plakophilin-1 is unknown. Plakophilin-1 immunos-
taining of dysplasia samples often revealed a decrease in
overall intensity, especially in the nuclear plakophilin-1
pool (Figure 3(b)). Nuclear plakophilin-1 was only rarely
and weakly observed in dysplastic and oral SCC samples.
Plakophilin-1 localization in oral SCC samples was most
often diﬀusely localized in the cytoplasm with little to no
nuclear signal (Figure 3(c)). Complete loss of cell border
association of plakophilin-1 was often seen in the oral SCC
samples (data not shown).
Scoring of the antiplakophilin-1 signal in these tissues
revealed an overall slight decrease in the dysplastic tissues
compared to normal oral mucosa although this change was
not signiﬁcant. Comparison of plakophilin-1 staining in oral
SCC samples to staining in normal oral mucosa revealed
a signiﬁcant decrease in plakophilin-1 immunoreactivity
between these tissue samples (Figure 5). Consistent with
previous reports, plakophilin-1 staining is decreased in SCC
comparedtonormaltissue[7,24,27];howeverplakophilin-1
is not signiﬁcantly decreased in dysplastic tissues.
Desmoglein-1isatransmembranedesmosomalcadherin
most highly expressed in the diﬀerentiated layers of the
epidermis. In our oral mucosa samples, this diﬀerentiation
speciﬁc desmosomal cadherin was highly expressed in all
the living layers of normal oral mucosa unlike skin where
desmoglein 1 expression is restricted to the most diﬀer-
entiated cell layers [28]. Interestingly, we observed robust
desmoglein-1 signal in dysplastic tissues and in oral SCC6 Dermatology Research and Practice
samples. The staining intensity of the antidesmoglein-1
signal was often slightly reduced; however we consistently
observed signiﬁcant desmoglein-1 protein in all of the
samples we observed (Figure 4). Although desmoglein-1
localization in oral SCC was at cell borders, it was possible
to also observe some cytoplasmic punctuate signal near cell
borders. This altered localization was consistently observed
in all the oral SCC samples. Scoring of the antidesmoglein-1
staining in these tissues did not reveal a signiﬁcant change in
anti-desmoglein-1 immunoreactivity between our samples.
Althoughoursamplesizeisrelativelysmall,weareableto
detect clearly signiﬁcant changes in desmoplakin immunore-
activity between normal and dysplastic oral epithelium
suggesting that disruption of desmosomal adhesion may
be an early event in the progression to oral SCC. In
addition, changes in plakophilin-1 expression appear at
a later stage compared to changes seen for desmoplakin
immunoreactivity, possibly in response to altered keratin
intermediate ﬁlament attachment at sites of cell-cell contact.
In our samples, desmoglein-1 immunoreactivity was
not signiﬁcantly altered between normal and oral SCC
samples. This ﬁnding is in disagreement with a recent
study that showed an inverse correlation of desmoglein-1
expression and poor prognosis of head and neck squamous
cell carcinoma patients [29]. The relatively small size of our
sample pool may explain the diﬀerences observed between
the two studies. The distribution of desmoglein-1 was often
disrupted and was not concentrated at cell borders but was
rather diﬀuse throughout the cells, most likely on the cell
surface (Figure 4(c)). Based on the loss of the desmosomal
plaque proteins, desmoplakin and plakophilin-1, diﬀuse
localization of desmoglein-1 is not unexpected. Examination
of these cell adhesion markers, particularly desmoplakin, in
dysplastic tissues may provide a good marker of tissues at
increased risk for progression to oral SCC.
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